Clinical and laboratory observationSerial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease*
References (11)
- et al.
Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease
Lancet
(1989) - et al.
Two monokines, interleukin-1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome
J Exp Med
(1986) - et al.
Cachectin and tumor necrosis factor as two sides of the same biological coin
Nature
(1986) - et al.
Interferon beta 2/B cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulatory factor and regulates the major acute phase protein response in liver cells
Proc Natl Acad Sci USA
(1987) - et al.
Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils
J Clin Invest
(1989)
There are more references available in the full text version of this article.
Cited by (159)
Single cell RNA-seq resolution revealed CCR1<sup>+</sup>/SELL<sup>+</sup>/XAF<sup>+</sup> CD14 monocytes mediated vascular endothelial cell injuries in Kawasaki disease and COVID-19
2023, Biochimica et Biophysica Acta - Molecular Basis of DiseaseKawasaki Disease
2017, Principles and Practice of Pediatric Infectious DiseasesA master role for neutrophils in Kawasaki syndrome
2017, Immunology LettersPredisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
2016, Drug Discovery Today
- *
Supported by a grant from the Institute of Biomedical Sciences, Academia Sinica in Taiwan, Republic of China.
Copyright © 1992 Published by Mosby, Inc.